These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 35571038)

  • 1. Association Between the
    Zhao L; Yin XX; Qin J; Wang W; He XF
    Front Genet; 2022; 13():807466. PubMed ID: 35571038
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of association studies and a systematic review and meta-analysis of CYP1A1 T3801C and A2455G polymorphisms in breast cancer risk.
    Yang C; He XF
    PLoS One; 2021; 16(4):e0249632. PubMed ID: 33909612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between
    Han X; Zheng L; Mu YY; Li HZ; He XF
    Front Genet; 2022; 13():1032110. PubMed ID: 36437941
    [No Abstract]   [Full Text] [Related]  

  • 4. Three common TP53 polymorphisms in susceptibility to breast cancer, evidence from meta-analysis.
    Hu Z; Li X; Yuan R; Ring BZ; Su L
    Breast Cancer Res Treat; 2010 Apr; 120(3):705-14. PubMed ID: 19657731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Association Studies and Meta-Analyses of
    Wang D; Liu L; Zhang C; Lu W; Wu F; He X
    Front Genet; 2022; 13():887415. PubMed ID: 35832187
    [No Abstract]   [Full Text] [Related]  

  • 6. Association Between
    Meng H; Huang S; Yang Y; He X; Fei L; Xing Y
    Front Genet; 2021; 12():698590. PubMed ID: 34899823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of TP53 16-bp and β-TrCP 9-bp INS/DEL polymorphisms in relation to risk of breast cancer.
    Eskandari-Nasab E; Hashemi M; Amininia S; Ebrahimi M; Rezaei M; Hashemi SM
    Gene; 2015 Sep; 568(2):181-5. PubMed ID: 26003292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between the p53 polymorphisms and breast cancer risk: meta-analysis based on case-control study.
    He XF; Su J; Zhang Y; Huang X; Liu Y; Ding DP; Wang W; Arparkorn K
    Breast Cancer Res Treat; 2011 Nov; 130(2):517-29. PubMed ID: 21604156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1β+3953C/T, -511T/C and IL-6 -174C/G polymorphisms in association with tuberculosis susceptibility: A meta-analysis.
    Mao X; Ke Z; Liu S; Tang B; Wang J; Huang H; Chen S
    Gene; 2015 Nov; 573(1):75-83. PubMed ID: 26169021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Individual and combined effects of GSTM1, GSTT1, and GSTP1 polymorphisms on breast cancer risk: A meta-analysis and re-analysis of systematic meta-analyses.
    Miao LF; Ye XH; He XF
    PLoS One; 2020; 15(3):e0216147. PubMed ID: 32155154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of any Association between the Hogg1 Ser326Cys Polymorphism and Breast Cancer Risk: a Systematic Review And Meta-Analysis Of 18 Studies.
    Kamali M; Kargar S; Heiranizadeh N; Zare M; Kargar Sh; Zare Shehneh M; Neamatzadeh H
    Asian Pac J Cancer Prev; 2017 Jan; 18(1):245-251. PubMed ID: 28240527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.
    Tang W; Chen Y; Wang Y; Gu H; Chen S; Kang M
    Int J Clin Exp Med; 2015; 8(8):12226-38. PubMed ID: 26550133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the rs1042522 polymorphism in
    Fan S; Hao ZY; Zhang M; Liang CZ
    Chronic Dis Transl Med; 2017 Jun; 3(2):95-104. PubMed ID: 29063062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women.
    Lajin B; Alhaj Sakur A; Alachkar A
    Breast Cancer Res Treat; 2013 Apr; 138(2):611-9. PubMed ID: 23468244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of MDM2 rs2279744 and TP53 rs1042522 polymorphisms with cervical cancer risk: A meta-analysis and systematic review.
    Yu M; Zhang Q; Zhao X
    Front Oncol; 2022; 12():973077. PubMed ID: 36059664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of Interleukin-10 Polymorphism (rs1800896, rs1800871, and rs1800872) With Breast Cancer Risk: An Updated Meta-Analysis Based on Different Ethnic Groups.
    Li L; Xiong W; Li D; Cao J
    Front Genet; 2022; 13():829283. PubMed ID: 35186043
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between the TP53 polymorphisms and lung cancer risk: a meta-analysis.
    Ye XH; Bu ZB; Feng J; Peng L; Liao XB; Zhu XL; Sun XL; Yu HG; Yan DF; Yan SX
    Mol Biol Rep; 2014 Jan; 41(1):373-85. PubMed ID: 24271138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between the combined effects of GSTM1 present/null and CYP1A1 MspI polymorphisms with lung cancer risk: an updated meta-analysis.
    Zhang WP; He XF; Ye XH
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32945337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis.
    Zhang K; Zhang L; Zhou J; Hao Z; Fan S; Yang C; Liang C
    Onco Targets Ther; 2016; 9():567-77. PubMed ID: 26869801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 codon 72 Polymorphism and bladder cancer risk: a meta-analysis and emphasis on the role of tumor or smoking status.
    Zhang L; Wang Y; Qin Z; Li R; Cong R; Ji C; Meng X; Wang Y; Xia J; Song N
    J Cancer; 2018; 9(19):3522-3531. PubMed ID: 30310509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.